Zobrazeno 1 - 1
of 1
pro vyhledávání: '"V. S. Chistiakov"'
Autor:
M. Yu. Fedyanin, A. V. Snegovoy, V. V. Breder, Yu. N. Linkova, A. V. Zinkina-Orikhan, S. B. Setkina, S. N. Fogt, V. S. Chistiakov, N. A. Kravtsova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 2, Pp 215-230 (2023)
In recent years, there has been a significant increase in the number of patients with malignancies treated with immune checkpoint inhibitors (ICIs), including the anti-programmed cell death protein 1 (anti–PD-1) agent pembrolizumab. One of the impo
Externí odkaz:
https://doaj.org/article/37fb3277a00a434a919575561dd41b36